Comparing treatment options for mid-low rectal cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the efficacy, prognosis, and health economics of various treatment modalities for mid-low rectal cancer across different centers in China. It will conduct a cost utility analysis to identify the most effective treatment strategies that align with the needs of medical units at various levels. The findings are expected to inform evidence-based medical guidelines and improve decision-making in medical management and insurance for rectal cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* pathologically confirmed rectal adenocarcinoma
* located within 12cm below the anal verge

Exclusion Criteria:

* diagnosed with distant metastasis
* multiple primary colorectal cancers
* history of previous malignant tumors
* Pregnant or lactating women

Where it's running

• Peking Union Medical College Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Yi Xiao, Professor
• Email: Xiaoy@pumch.cn
• Phone: +86 13366036387

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Characterization of the tumor microenvironment in locally advanced rectal cancer before and during neoadjuvant therapy

  This observational study tests how the tumor and immune cells change in locally advanced rectal cancer from baseline to during neoadjuvant therapy using advanced genomic and immune profiling.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07920770

• Neoadjuvant therapy for locally advanced low rectal cancer: adding fruquintinib to short-course radiotherapy with tislelizumab and CAPOX

  This study tests whether adding fruquintinib to short-course radiotherapy plus tislelizumab and CAPOX before surgery helps people with locally advanced low rectal cancer achieve a better tumor response.

  Recruiting Phase 2 Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07888309

• Gut and tumor bacteria patterns in metastatic versus non-metastatic colorectal cancer

  This project will test whether bacteria in the gut and tumor differ between people whose colorectal cancer has spread and those whose cancer has not to see if bacterial signatures can help predict spread.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07154173

• Comparing two surgical techniques for anal function after low rectal cancer surgery

  This study is testing which of two surgical methods helps people with ultra-low rectal cancer have better bowel control and quality of life after surgery.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT05943444

• Platform program for evaluating treatments in metastatic HER2-positive breast cancer

  This study is testing different new treatments for people with advanced HER2-positive breast cancer to see which ones work best before moving them to larger trials.

  Recruiting at 5 sites Phase 1/2 QuantumLeap Healthcare Collaborative · Birmingham, Alabama and 9 other locations · NCT05868226

• Effects of aerobic exercise on muscle changes in colorectal cancer survivors

  This study tests if doing aerobic exercise can help improve muscle health in people who have survived colorectal cancer compared to those who are not exercising.

  Recruiting AdventHealth Translational Research Institute · Orlando, Florida · NCT05789433

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.